[Evaluation of p21 and lung resistance protein (LRP) as a factor suggesting breast cancer recurrence].
Oide
H
H
Minegishi
A
A
Kobayashi
S
S
Suzuki
S
S
Takashima
K
K
D001943:Breast Neoplasms / Q000737:chemistry* / Q000401:mortality; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000032:analysis*; D018432:Drug Resistance, Multiple; D006801:Humans; D009363:Neoplasm Proteins; D015996:Survival Rate; D020394:Vault Ribonucleoprotein Particles; D000099187:Major Vault Protein
D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D009363:Neoplasm Proteins; D020394:Vault Ribonucleoprotein Particles; D000099187:Major Vault Protein; C493956:CDKN1A protein, human